-
-
New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions
-
Hospital pharmacy directors can view REMS as a positive move forward in patient safety or as an unfunded mandate that will cost them valuable staff time. Either way, it's certain they'll need to move REMS to the top of their priority list.
-
Pharmacists will be closely involved with helping the FDA monitor the Risk Evaluation and Mitigation Strategy (REMS) as increasing numbers of drugs are added to the REMS list.
-
As the world has focused on millions of gallons of oil spilling into the ocean from the BP off-shore drilling disaster, another waterway issue is beginning to impact how hospitals and nursing homes handle pharmaceutical waste.
-
Many hospitals and other employers are moving toward a fair and respectful culture in which there is no tolerance for rude supervisors and annoying coworkers.
-
Hospital pharmacy directors should expect some continued work and complications even after they've successfully installed new technology to assist with improving medication safety.
-
-
Pharmacy directors across the nation already have identified some problems with the FDA's Risk Evaluation and Mitigation Strategy (REMS) process as announced in the last year.
-
The days of hospitals putting up with a "House, M.D." personality are fading away as pharmacy managers and others find that hospital cultures are moving toward a more respectful atmosphere.
